Introduction. Hypertensive disorders of pregnancy (HDP) tend to recur from one pregnancy to the next. The aims of the study were to assess the recurrence risk according to type of HDP defined by gestational age at birth and to examine whether recurrence is associated with the following additional risk factors for HDP: maternal age, smoking, inter-delivery interval, diabetes, body mass index, and fetal growth restriction, and to assess temporal trends in these associations. Material and methods. All women with two singleton births in the Medical Birth Registry of Norway 1967-2012 (n = 742 980) were included in this population-based cohort study. Logistic regression was used to calculate odds ratios for the risk of recurrent HDP according to type of HDP. Results. The highest odds ratio of recurrence was observed for the same type of HDP based on gestational age at delivery. After gestational hypertension and term preeclampsia, the risk for the same type to recur increased 10-fold, whereas after late and early preterm preeclampsia, the risk increased 27-and 97-fold, respectively. The recurrence of early preterm preeclampsia was less influenced by additional risk factors compared with term HDP. Recurrence of early preterm HDP was significantly lower from 1993 onwards.
Introduction
The association between preeclampsia (PE) and birth order is well established. In the first pregnancy, PE is observed in 3-7% of all births, whereas in parous women the rate is less than 2% (1) (2) (3) (4) . Still, in a pregnancy subsequent to a PE pregnancy, the recurrence risk is high. In large population-based studies, recurrence risks up to 21% have been observed (1, 3, 5) . However, recurrence studies of hypertensive disorders of pregnancy [HDP, PE or gestational hypertension (GH)] according to severity of the condition in the first pregnancy are scarce. A large, individual patient data meta-analysis of subsequent pregnancies in women having experienced HDP in previous pregnancies indicated that the disease was milder when it
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Preterm hypertensive disorders of pregnancy (HDP) tend to recur more often than term HDP, whereas other risk factors for HDP have a stronger effect on recurrence of term HDP. The time trend for recurrence of early preterm HDP is declining in Norway. recurred (6) . HDP in general and particularly PE represent serious threats to both the mother and the offspring (2, 7) . Thus, a history of PE leading to preterm delivery may deter a woman from having another child (1) . Accordingly, predicting the risk of recurrent PE represents an important challenge to counseling.
A number of more or less modifiable additional risk factors for HDP have been established: high maternal age, a long inter-delivery interval (4, 8) , diabetes, a growthrestricted baby in the previous pregnancy (9) , and maternal obesity (10) (11) (12) increase the risk, whereas an apparent protective effect of smoking late on pregnancy has been observed (13, 14) . In the process of counseling a woman after a pregnancy with HDP, these factors have to be taken into consideration.
Acknowledging the fact that HDP comprises conditions with a wide range of severity, the objective of the present study was to predict the risks of recurrence according to severity, and to assess possible effects of additional risk factors on the recurrence of HDP.
Even with the current lack of knowledge of pathogenic mechanisms in PE, a number of prophylactic efforts have been made. Around 1995, intervention with low-dose aspirin was recommended as a secondary prophylaxis starting during the late first or early second trimester in pregnancies following early onset PE, and from 1998 this was included in the national guidelines (15) . Thus, we also wanted to explore whether a decrease occurred in the recurrence of early onset HDP over time.
Material and methods
Established in 1967, the Medical Birth Registry of Norway comprises records of all pregnancies in the country with a gestational age exceeding 16 weeks, and since 1999 all pregnancies exceeding 12 weeks. Research ethics committees in Norway exempt research on anonymous registry data from ethical review. The compulsory notification by attending midwives and doctors includes a range of personal and medical data (16) . Use of the national identification number ensures linkage of all pregnancies of a woman. The study comprised all women with a first and a second singleton birth registered in 1967-2012 with known gestational age at delivery, based on the mother's last menstrual period or, if missing, on ultrasound estimations, altogether 742 980 women. The main exposure was type of HDP based on gestational age at birth in the first pregnancy, and the outcome was type of HDP in the second pregnancy. HDP included GH (non proteinuric hypertension) and PE notified as clinical diagnoses; 1967-1998 in terms of free text and from 1999 onwards by checking boxes. PE types were defined according to gestational age in completed weeks at birth: term = 37+, late preterm = 33-36, and early preterm = 25-32. Clinical criteria of HDP in Norway have been in accordance with those established by the American College of Obstetricians and Gynecologists (17) . Other exposures were the size of the neonate in the first delivery (small for gestational age), maternal age, inter-delivery interval, smoking, pre-existing diabetes mellitus, and body mass index (BMI). Small for gestational age was defined as a birthweight below the 10th gender-and birth order-specific gestational age percentile based on the study population. High maternal age was defined as 35 years or more at the second birth. Smoking was defined as occasional or daily cigarette use at the beginning of the second pregnancy. Data on maternal smoking habits were included in the registry from 1998. Long inter-delivery interval was defined as 6 years or more between the first and the second delivery. Preexisting diabetes mellitus was defined as type 1 or 2 diabetes diagnosed before the second pregnancy. Registration of maternal height and weight was initiated in 2006, and BMI was calculated as bodyweight in kilograms divided by height in meters, squared. We categorized the population in two sections: BMI <25 was defined as normal, and BMI ≥25 as pre-obesity and obesity. Women with missing information on BMI were excluded from the analyses that involved BMI. The data regarding smoking were dichotomized, and missing information on smoking was coded as "no". Characteristics of the second pregnancy for women with and without HDP are shown in Table 1 .
Statistical analyses
HDP categorized by gestational age at birth in the index pregnancy as described above was main exposure, and HDP categorized in the same way for the subsequent pregnancy was outcome. Risks of recurrence were estimated as odds ratios (OR) with 95% confidence intervals (CI). Women with no HDP in the first pregnancy comprised the reference group. The effects of the additional variables were assessed by ORs. We stratified the population based on 5-year periods for the second birth. The Statistical Package for the Social Sciences for Windows version 22 (SPSS, Chicago, IL, USA) was used for the statistical analyses.
Results
In the first pregnancy, HDP occurred in 43 710, or 5.9% of all women; 1.8% had GH, 3.4% had term PE, 0.5% had late preterm PE, and 0.2% had early preterm PE (Table 2 ). In the second pregnancy, HDP occurred in 9029, or 1.2% of all women. However, among women with HDP in the first pregnancy, HDP recurred in 20.7% of the pregnancies. Recurrence of HDP was dependent on type of HDP in the first pregnancy defined by gestational age at the first delivery ( Figure 1) ; women with preterm PE in the first pregnancy had the highest risk of recurrence of HDP, 30.4% after late preterm PE and 39.4% after early preterm PE. Compared with the risk in women without HDP in the first pregnancy, the OR of HDP in the second pregnancy amounted to around 15. After GH and term PE, the recurrence risk of HDP was around 19%, with an OR of recurrence around 8 (Table 2) . Furthermore, HDP tended to recur as HDP with delivery at the same gestational age. Type-specific ORs of recurrence of GH and term PE were around 10, compared with those of late and early PE, 27.7 and 97.0, respectively (Table S1 ).
There was a tendency for the effects of the additional risk factors for recurrence of HDP to be stronger for term type of HDP in the first pregnancy, and strongest for women without HDP in the first pregnancy. Furthermore, the effects expressed as preterm PE were stronger than the effects expressed as term PE (Table 3) . As an example, a woman without HDP in the first pregnancy and who was 35 years or older at the second birth and with a long inter-delivery interval (6 years or more) had a fourfold excess risk of preterm PE and a twofold risk of term PE (Table 3) in the next pregnancy. Likewise, the risk associated with having GH in the first pregnancy in addition to high maternal age and long inter-delivery interval was tripled for preterm PE in the second pregnancy (Table 3) . Following early preterm PE, only high maternal age and diabetes significantly increased the risk of preterm PE in the next pregnancy (Table 3 ). The effect of the combination of high maternal age and long inter-delivery interval was less than additive. Interestingly, preexisting diabetes increased the risk of preterm PE in the second pregnancy regardless of severity of HDP in the first pregnancy (Table 3) , and with a particularly strong effect on the occurrence of preterm PE (OR 9.9). In sub-analyses exploring the effect of preexisting type 1 and 2 diabetes separately, no effect of type 2 diabetes was observed, except for the occurrence of HDP in a pregnancy following a non-HDP pregnancy (data not shown). In general, recurrence after an early preterm PE pregnancy to term HDP was not influenced by any of the additional risk factors (Table 3) , whereas recurrence after term HDP to a preterm PE type was more often influenced by the additional risk factors, except smoking (Table 3) .
Among new onset HDP, GH (hypertension without proteinuria) is considered the mildest type. GH was rare in preterm deliveries: 718 first pregnancies (0.1% of the total population, and 5.4% of those with GH in the first pregnancy) and 541 second pregnancies (0.07% of the total population, and 5.6% of those with GH in the second pregnancy). Preterm GH recurred more frequently than term GH (OR 23.4, 95% CI 13.14-41.0 and OR 10.7, 95% CI 10.1-11.4, respectively). The risk of term GH recurring as preterm GH, and preterm GH recurring as term GH was lower (OR 8.8, 95% CI 6.9-11.1 and OR 7.8, 95% CI 6.1-10.1, respectively). Thus, even the risk of recurrence of GH was type-specific (based on gestational age at birth), the same pattern we found for recurrence of PE. The recurrence risk for preterm HDP after preterm GH was approximately doubled compared with the recurrence risk when the total group of GH was used as exposure (data not shown).
Superimposed PE refers to new onset proteinuria in women with chronic hypertension. In our population, 2498 women had chronic hypertension before the second pregnancy. Of these, 472 (18.9%) developed PE with an OR of 17.7 (95% CI 14.9-21.1), which is substantial.
A risk-lowering effect of smoking at the beginning of the second pregnancy was observed only on term HDP in the second pregnancy and in women with no HDP, term or late preterm PE in the first pregnancy (Table 3) . High BMI exerted the strongest effect on occurrence rather than recurrence of HDP. In pregnancies following an HDP pregnancy, a high BMI doubled the risk of developing term PE (OR 1.9, 95% CI 1.5-2.5), and almost tripled the risk of developing term PE following a non-HDP pregnancy (OR 2.7, 95% CI 2.3-3.3). While the risk of recurrent preterm PE was not significantly increased by high BMI, the risk of preterm PE following a non-HDP pregnancy was almost tripled (OR 2.8, 95% CI 1.9-4.1).
The sex of the child in the second birth did not influence recurrence (data not shown.) A significant reduction in OR of recurrence of early preterm PE was observed from 1988-1992 to 1993-1997 ( Figure 2) ; in the first 5-year period, the OR of recurrence was 99.0 (95%CI 66.6-147.2) vs. 35.8 (95% CI 23.1-55.7) in the second period. Adjusting for maternal age did not change the pattern. The recurrence of late preterm and term HDP was stable (Figure 2 ).
Discussion
In a pregnancy following an HDP pregnancy, the risk of HDP was increased, and the type of the recurrent HDP in terms of gestational age at birth was dependent on gestational age at birth in the first pregnancy. After HDP in the first pregnancy, the highest OR of recurrence was consistently observed for the same type of HDP (Tables 2 and S1, Figure 1 ). The strength of the association increased with severity of the condition in the first pregnancy; after GH and term PE, the type-specific OR of recurrence was around 10, whereas after late and early preterm PE, the OR increased to 27 and 97, respectively, compared with women without HDP in the first pregnancy.
In general, our results indicate that the risk after an early preterm PE is influenced less by the additional risk factors, with the exception of maternal age and pre-pregnancy diabetes, whereas the risk after term HDP and GH as well as no HDP in the first pregnancy is significantly influenced by the additional factors (Table 3) . A high BMI had the strongest effect on occurrence rather than recurrence of HDP. In women with recurrent HDP, 66% had a high BMI as opposed to 34% in women with no HDP (Table 1) .
The recurrence of early preterm HDP was significantly lower in more recent periods, whereas there was no significant change in recurrence of late preterm or term HDP (Figure 1 ). The study is population-based and comprises all births in Norway during 1967-2012, providing power sufficient to assess the associations of interest.
The data are derived from the Medical Birth Registry of Norway, representing a continuous and standardized compulsory notification from 1967 onwards (16) . The diagnosis of HDP has been validated with satisfactory results (18, 19) . The grade of severity of the condition was based on gestational age at delivery by last menstrual period or ultrasound. The registry also contains information on maternal risk factors. We did not have access to social and demographic factors (such as level of education or ethnicity, and change of paternity). Immigrant women in Norway have PE less often than Norwegian women, both in the first and subsequent pregnancies (20) . The fraction of immigrants' deliveries in Norway has been increasing (from 14% in 2000 to 27% in 2014) (21) . The recurrence risk of HDP in immigrants is not known. Adjusting for education would most likely not affect the results, as education is weakly or not associated with HDP (22) . A limitation was that data on maternal BMI were available only for a subset of women. However, in this subset we found that pre-obesity and obesity significantly increased the risk of both occurrence and recurrence.
Misclassification of the exposure, viz. HDP in the first pregnancy and the additional factors is not very likely, but misclassification of the outcome, HDP in the second pregnancy, is possible. A preterm PE in the first pregnancy could possibly increase the likelihood of initiating a preterm clinical intervention, shortening the gestational age at second birth and thereby contributing to a high recurrence of preterm PE, and probably more so towards the end of the observation period, when intervention became more frequent.
Our study confirms the findings of previous studies (1); HDP was less frequent in the second than the first pregnancy, 3.3% vs. 5.9%. The individual patient data meta-analyses of recurrent HDP include data from the Medical Birth Registry of Norway (6); however, our study covers all women with two subsequent pregnancies, thus including women without HDP in the first and second pregnancy (Table 1) , which allows us to calculate ORs. The individual patient data meta-analysis (6) reported that HDP was milder when it recurred. However, in the present study, the proportions of term HDP among all types of HDP in the first and second pregnancy were equal (88-89%). Preterm HDP was more likely than term HDP to recur after any type of HDP, and particularly preterm HDP (ORs of recurrence 27-97; Table S1 ). This is in line with a study of delivery blood pressure and risk of HDP in a subsequent pregnancy (23) .
The effect of smoking in the second pregnancy represented a small risk reduction, and only if the outcome was term HDP in the second pregnancy (Table 3) . This is in line with the results of other studies (13) . We cannot rule out a dilution of a possible weak effect of smoking since missing information on smoking was coded "no". Evidence indicates that HDP has a multifactorial etiology involving genetic factors (3, 24) with potential bearings also on long-term survival (7, 25) . However, modifiable risk factors such as those included in the present study are also involved. Our findings are consistent with a pattern implying that the effects of the modifiable risk factors are stronger for occurrence than for recurrence. For recurrence, the effects of these factors were particularly strong after GH and term HDP in the first pregnancy (Table 3) .
Previous studies have discussed whether HDP represents an etiologically heterogeneous disorder (10, 26) . Thus, we have recently suggested that one type of PE referred to as "trophoblastic" has an early onset with fetal growth restriction, whereas another is referred to as "non-trophoblastic" late onset with fetal-placental overgrowth often observed in obese women (10) . The pattern of recurrence shown in the present study further supports this hypothesis: the high risk of recurrence of early preterm PE and the low risk of term HDP are consistent with permanent, often genetic and transient risk factors, respectively (1,10). Redman et al. suggest an alternative hypothesis that also fits with early and late preeclampsia, where the first type is associated with fetal growth restriction and dysfunctional placentation, whereas the late-onset form is not. This also fits with different patterns of biomarkers of the two types of preeclampsia (27) . Tables 2 and S1 and Figure 1 provide clinically important data of value in counseling based on the different types of HDP observed in the first pregnancy. Thus, after early preterm PE, the risk of any HDP in the next pregnancy was almost 40%.
Preexisting diabetes increased the risk of developing preterm PE regardless of the severity of HDP in the first pregnancy, in fact the effect was of the same magnitude or stronger in pregnancies following a non-HDP pregnancy (Table 3) . A high type-specific recurrence may to some extent be due to the fact that type is defined by gestational age at birth, which tends to recur from one pregnancy to the next (28) .
The lower risk of recurrence of early preterm PE in the last part of the study period could not be explained by demographic changes. Thus, changes in clinical practice such as introducing prophylaxis with low-dose aspirin in the high-risk group (15, 29) may have contributed to the risk reduction observed in the last period ( Figure 2 ). The observed change in risk coincided with emerging evidence of the protective effect of aspirin in pregnancies subsequent to pregnancies complicated by early preterm HDP or severe growth restriction from the mid-1990s and the implementation of this prophylaxis in Norwegian national guidelines. The risk did not change in late preterm or term HDP, which fits with secondary prophylaxis for PE not being recommended after a pregnancy with late preterm PE or GH. Whether secondary prophylaxis with aspirin to women who have experienced early preterm HDP can explain the observed decline in the recurrence of the condition in our population needs to be studied further.
In terms of counseling, it appears that the risk factors studied confer little additional risk to women with a first early preterm HDP pregnancy. However, in women with no late preterm or term HDP in the first pregnancy, significant effects of the additional factors were observed. This is important information in counseling: in a case of early preterm PE, the condition has an extremely high risk to recur irrespective of additional factors, whereas in a case with a late preterm or term HDP first pregnancy, the importance of the additional factors should be stressed; if possible, she should not postpone a second pregnancy, and she should be given lifestyle advice to avoid obesity in order to lower the risk in a following pregnancy.
